1,538 results on '"Djulbegovic, Benjamin"'
Search Results
2. Formulating Management Strategies Using Fast-and-Frugal Trees (A Decision Tool to Transform Clinical Practice Guidelines and Clinical Pathways into Decision Support at the Point of Care)
3. Hybrid and Dual-Processing Threshold Decision Models
4. Which Threshold Model?
5. Medical Decision-Making and Artificial Intelligence
6. Using Decision Curve Analysis to Evaluate Testing and/or Predictive Modeling
7. Decision-Making When Diagnostic Testing is Available
8. Making Decisions When no Further Diagnostic Testing is Available (Expected Regret Theory Threshold Model)
9. Evidence and Decision-Making
10. Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines
11. High certainty evidence is stable and trustworthy, whereas evidence of moderate or lower certainty may be equally prone to being unstable
12. Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis
13. Methods proposed for monitoring the implementation of evidence-based research: a cross-sectional study
14. Guideline panel social dynamics influence the development of clinical practice recommendations: a mixed-methods systematic review
15. Increasing FDA-accelerated approval of single-arm trials in oncology (1992 to 2020)
16. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer
17. Threshold Decision-making in Clinical Medicine
18. Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible
19. What is the probability that higher versus lower quality of evidence represents true effects estimates?
20. A few panel members dominated guideline development meeting discussions: Social network analysis
21. Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for VTE prophylaxis
22. Distinguishing ASH Clinical Practice Guidelines from Other Forms of ASH Clinical Advice
23. Ethics of uncertainty
24. Certainty of evidence and intervention's benefits and harms are key determinants of guidelines’ recommendations
25. Biomarker-derived fast-and-frugal decision tree for preemption of veno-occlusive disease/sinusoidal obstructive syndrome
26. GRADE Guidelines 30: the GRADE approach to assessing the certainty of modeled evidence—An overview in the context of health decision-making
27. GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes—Study limitations due to censoring of participants with missing data in intervention studies
28. Benchmarking treatment effects for patients over 70 with acute myeloid leukemia: A systematic review and meta-analysis
29. A user guide to the American Society of Hematology clinical practice guidelines
30. Improving methods of clinical practice guidelines: From guidelines to pathways to fast‐and‐frugal trees and decision analysis to develop individualised patient care
31. Guideline panel social dynamics influence the development of clinical practice recommendations: A mixed-methods systematic review
32. Panel stacking is a threat to consensus statement validity
33. Thrombophilia management calculator
34. Structured decision-making drives guidelines panels' recommendations “for” but not “against” health interventions
35. Methodological review showed correct absolute effect size estimates for time-to-event outcomes in less than one-third of cancer-related systematic reviews
36. Evidence, values, and masks for control of COVID-19: 2 years later
37. Evidence to Decision framework provides a structured “roadmap” for making GRADE guidelines recommendations
38. The EGAPP initiative: lessons learned
39. Improving methods of clinical practice guidelines: From guidelines to pathways to fast‐and‐frugal trees and decision analysis to develop individualised patient care.
40. Decision curve analysis based on summary data.
41. Hematology Referral Madness Syndrome
42. Larger effect sizes in nonrandomized studies are associated with higher rates of EMA licensing approval
43. Hematological Malignancies and Arterial Thromboembolism
44. Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer
45. Sorites paradox and persistence in overuse and underuse in healthcare delivery services
46. Clinical Equipoise and the Therapeutic Misconception
47. Progress in evidence-based medicine: a quarter century on
48. Stakeholders apply the GRADE evidence-to-decision framework to facilitate coverage decisions
49. Acceptable regret model in the end-of-life setting: Patients require high level of certainty before forgoing management recommendations
50. Generalised decision curve analysis for explicit comparison of treatment effects.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.